Background Systemic arterial hypertension is one of the major risk factors for the development of chronic kidney disease and nephroangiosclerosis. Progressive extracellular matrix deposition, interstitial fibrosis, and arteriolosclerosis contribute to increased renal parenchymal stiffness. Shear Wave elastography (2D-SWE) enables non-invasive quantification of Young’s modulus (expressed in kPa); however, its clinical value in hypertensive kidneys remains controversial. Aim To assess the feasibility and accuracy of cortical 2D-SWE for estimating renal stiffness in a cohort of hypertensive patients compared with healthy controls, and to investigate its correlations with anthropometric parameters, Doppler-derived hemodynamic indices (mean resistive index, RI), and renal function markers (serum creatinine). Materials and Methods This prospective, single-center pilot study (K-STRESS study) included 105 participants: 46 hypertensive patients and 59 healthy volunteers serving as controls. All participants underwent conventional 2D ultrasound and spectral Color Doppler ultrasound to calculate the mean resistive index (RI), 2D-SWE elastography using a Samsung RS85 ultrasound system equipped with a 1–7 MHz convex probe (12 cortical measurements per kidney), and reference liver stiffness assessment. Serum creatinine levels were also measured. Results Analysis of anthropometric and clinical data revealed statistically significant differences between the two groups in median age (58 years in hypertensive patients vs. 34 years in healthy controls, p < 0.001) and abdominal circumference (91 cm vs. 83 cm, respectively; p = 0.024). As expected, blood pressure values were significantly higher in the hypertensive group than in the control group, both for systolic blood pressure (SBP: 138 mmHg vs. 120 mmHg, p < 0.001) and diastolic blood pressure (DBP: 85 mmHg vs. 70 mmHg, p < 0.001). No statistically significant differences were observed in sex distribution, weight, height, or body mass index (BMI). Assessment of renal function showed significantly higher serum creatinine levels in hypertensive patients than in healthy controls (72.5 μmol/L vs. 61.0 μmol/L, p = 0.016). Regarding renal hemodynamics, the mean resistive index (RI) was significantly higher in hypertensive patients than in healthy controls (0.64 vs. 0.59, p < 0.001). Furthermore, within the hypertensive group, a significant positive linear correlation was observed between mean RI and serum creatinine levels (p = 0.03). No statistically significant differences in SWE-derived parameters were found between the two study groups. Conclusion In hypertensive patients, the mean renal resistive index (RI) appears to be a sensitive hemodynamic marker and is associated with serum creatinine levels (p = 0.03). In contrast, cortical 2D-SWE showed limited ability to discriminate between hypertensive patients and healthy controls, likely reflecting the multifactorial determinants of renal stiffness in vivo, including renal hemodynamic status, skin-to-kidney distance, disease duration, blood pressure variability, region-of-interest (ROI) placement, and transducer pressure. Therefore, the assessment of hypertensive renal parenchymal damage requires an integrated multiparametric approach combining B-mode ultrasound, Doppler indices, elastography, and blood biomarkers.
Background L'ipertensione arteriosa sistemica è tra i principali fattori di rischio per lo sviluppo di malattia renale cronica e nefroangiosclerosi. Il progressivo deposito di matrice extracellulare, la fibrosi interstiziale e l'arteriolosclerosi aumentano la rigidità parenchimale. L'elastosonografia Shear Wave (2D-SWE) consente la quantificazione non invasiva del modulo di Young (in kPa); tuttavia, il suo valore clinico nel rene iperteso rimane dibattuto. Scopo dello studio Valutare la fattibilità e l'accuratezza della 2D-SWE corticale nella stima della rigidità renale in una coorte di pazienti ipertesi rispetto a controlli sani, analizzando le correlazioni con parametri antropometrici, indici emodinamici Doppler (IR medio) e marcatori di funzione renale (creatinina sierica). Materiali e metodi Studio pilota prospettico monocentrico (studio K-STRESS) condotto su 105 soggetti: 46 pazienti ipertesi e 59 volontari sani di controllo. Tutti i partecipanti sono stati sottoposti a ecografia 2D e Color-Doppler spettrale per il calcolo dell'Indice di Resistenza (IR medio), elastosonografia 2D-SWE (ecografo Samsung RS85, sonda convessa 1–7 MHz; 12 misurazioni per rene nella corticale e stima della rigidità epatica di riferimento) e dosaggio della creatinina sierica. Risultati L'analisi dei dati antropometrici e clinici ha evidenziato una differenza statisticamente significativa tra i due gruppi per l'età mediana (58 anni negli ipertesi e 34 anni nei controlli sani, p < 0,001), e per la circonferenza addominale, pari a 91 cm negli ipertesi rispetto a 83 cm nei controlli sani (p = 0,024). Come previsto dal protocollo, i valori pressori sono risultati significativamente superiori nel gruppo ipertesi rispetto ai sani, sia per la PAS (138 mmHg vs 120 mmHg, p < 0,001) che per la PAD (85 mmHg vs 70 mmHg, p < 0,001), mentre non sono emerse differenze statisticamente significative per sesso, peso, altezza e BMI. La valutazione della funzionalità renale ha mostrato livelli di creatinina sierica significativamente più elevati nei pazienti ipertesi rispetto ai controlli (72,5 μmol/L vs 61,0 μmol/L, p = 0,016). Dal punto di vista emodinamico, l'Indice di Resistenza (IR) medio renale è risultato significativamente più alto nei soggetti ipertesi rispetto ai sani (0,64 vs 0,59, p < 0,001); inoltre, nel solo gruppo degli ipertesi è emersa una correlazione lineare diretta e significativamente positiva tra l'IR medio e i valori di creatinina sierica (p = 0,03). Per quanto riguarda i parametri elastografici SWE, non sono state riscontrate differenze statisticamente significative tra i due gruppi di studio. Conclusione Nei pazienti ipertesi, l'Indice di Resistenza (IR) medio si conferma un indicatore emodinamico sensibile e correlato ai livelli di creatinina sierica (p = 0,03). Al contrario, la 2D-SWE corticale ha mostrato un'utilità limitata nel discriminare i pazienti ipertesi dai sani, a causa della natura multifattoriale della rigidità renale in vivo (stato dell’emodinamica renale, distanza cute-rene, durata della malattia, variabilità della pressione sanguigna, ROI di campionamento, pressione del trasduttore). La diagnosi del danno parenchimale ipertensivo richiede pertanto un approccio multiparametrico integrato che associ ecografia B-mode, indici Doppler, elastosonografia e biomarker ematici.
Shear wave elastography (SWE) per la valutazione della rigidità renale nel paziente affetto da ipertensione arteriosa sistemica: risultati preliminari dello studio pilota K-STRESS
BIGOLIN, FRANCESCO
2024/2025
Abstract
Background Systemic arterial hypertension is one of the major risk factors for the development of chronic kidney disease and nephroangiosclerosis. Progressive extracellular matrix deposition, interstitial fibrosis, and arteriolosclerosis contribute to increased renal parenchymal stiffness. Shear Wave elastography (2D-SWE) enables non-invasive quantification of Young’s modulus (expressed in kPa); however, its clinical value in hypertensive kidneys remains controversial. Aim To assess the feasibility and accuracy of cortical 2D-SWE for estimating renal stiffness in a cohort of hypertensive patients compared with healthy controls, and to investigate its correlations with anthropometric parameters, Doppler-derived hemodynamic indices (mean resistive index, RI), and renal function markers (serum creatinine). Materials and Methods This prospective, single-center pilot study (K-STRESS study) included 105 participants: 46 hypertensive patients and 59 healthy volunteers serving as controls. All participants underwent conventional 2D ultrasound and spectral Color Doppler ultrasound to calculate the mean resistive index (RI), 2D-SWE elastography using a Samsung RS85 ultrasound system equipped with a 1–7 MHz convex probe (12 cortical measurements per kidney), and reference liver stiffness assessment. Serum creatinine levels were also measured. Results Analysis of anthropometric and clinical data revealed statistically significant differences between the two groups in median age (58 years in hypertensive patients vs. 34 years in healthy controls, p < 0.001) and abdominal circumference (91 cm vs. 83 cm, respectively; p = 0.024). As expected, blood pressure values were significantly higher in the hypertensive group than in the control group, both for systolic blood pressure (SBP: 138 mmHg vs. 120 mmHg, p < 0.001) and diastolic blood pressure (DBP: 85 mmHg vs. 70 mmHg, p < 0.001). No statistically significant differences were observed in sex distribution, weight, height, or body mass index (BMI). Assessment of renal function showed significantly higher serum creatinine levels in hypertensive patients than in healthy controls (72.5 μmol/L vs. 61.0 μmol/L, p = 0.016). Regarding renal hemodynamics, the mean resistive index (RI) was significantly higher in hypertensive patients than in healthy controls (0.64 vs. 0.59, p < 0.001). Furthermore, within the hypertensive group, a significant positive linear correlation was observed between mean RI and serum creatinine levels (p = 0.03). No statistically significant differences in SWE-derived parameters were found between the two study groups. Conclusion In hypertensive patients, the mean renal resistive index (RI) appears to be a sensitive hemodynamic marker and is associated with serum creatinine levels (p = 0.03). In contrast, cortical 2D-SWE showed limited ability to discriminate between hypertensive patients and healthy controls, likely reflecting the multifactorial determinants of renal stiffness in vivo, including renal hemodynamic status, skin-to-kidney distance, disease duration, blood pressure variability, region-of-interest (ROI) placement, and transducer pressure. Therefore, the assessment of hypertensive renal parenchymal damage requires an integrated multiparametric approach combining B-mode ultrasound, Doppler indices, elastography, and blood biomarkers.| File | Dimensione | Formato | |
|---|---|---|---|
|
Bigolin_Francesco.pdf
Accesso riservato
Dimensione
2.54 MB
Formato
Adobe PDF
|
2.54 MB | Adobe PDF |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/120049